Latest Wanbury stock price

Wanbury P/E Ratio

WANBURY • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
23.52
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 23.52
Current Price ₹219.16
EPS (TTM) ₹9.32
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 8.17
Historical Range 6.78 - 9.56
Percentile 100.0%

Sector Context

Sector Average 57.32
Sector Median 35.38
Sector Rank #11 of 89
Sector Percentile 12.4%

Earnings Breakdown (TTM)

TTM EPS ₹23.02
Mar 2025 ₹6.18
Jun 2025 ₹4.12

Key P/E Ratio Insights for Wanbury

  • Current PE is 187.9% above historical average
  • Trading at discount to sector average PE of 57.32

View the WANBURY equity price for detailed stock performance.

P/E Ratio Historical Trend for Wanbury

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 9.56 13.42 ₹128.30 NSE Low
2023 6.78 7.13 ₹48.35 NSE Low

Sector P/E Ratio Comparison

Comparing Wanbury with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate